Nanomedicine News

RSS

BIND Biosciences Reports Positive Phase I Clinical Results on First Prostate Nanomedicine

A nanomedicine research project at the David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT) has delivered a first-of-its-kind nanomedicine capable of targeting prostate cancer cells and delivering high concentrations of docetaxel chemotherapy in Phase I clinical studies.

6 Apr 2012

LATITUDE Pharmaceuticals Creates Injectable Liquid Glucagon Formulation, Nano-G

Researchers at LATITUDE Pharmaceuticals have created a first-of-its-kind stable, injectable liquid glucagon formulation called Nano-G, which is based on the company’s injectable nanoemulsion drug delivery platform called Nano-E.

5 Apr 2012

Researchers Demonstrate Cargo-Carrying Bacteria to Deliver Nano-Medicine

At the American Chemical Society’s 243rd National Meeting & Exposition a research team led by David H. Gracias from the Johns Hopkins University has reported about a research on ‘backpacking’ bacteria that can serve as a carrier to deliver nano-medicine across the body.

From American Chemical Society 31 Mar 2012

Nanoparticle Paclitaxel with Carboplatin Effective than Commercial Gemcitabine-Carboplatin

Decision Resources, a research and consultative firm for pharmaceutical and healthcare issues, offers analysis on the latest developments in the non-small-cell lung cancer drug market.

30 Mar 2012

Comprehensive Book on Applied Aspects of Nanotechnology in Health Care

Research and Markets has added a new book, titled, "Nanotechnology in Health Care" to its collection.

From Research and Markets 28 Mar 2012

BIONOVA’s Skincare Products Now Include NANO-COMPLEX

When it made its entry into the beauty market, BIONOVA promised to offer healthy skin with unprecedented results through life science nanotechnology. Today, the company has succeeded in delivering the results it promised and has become one of the most trusted and well-known skincare brands.

28 Mar 2012

Nanofibers and Nanofilaments Offer Potential Solutions in Regenerative Medicine

According to Samuel I. Stupp, Ph.D., regenerative medicine can have a significant impact on healthcare cost and the quality of life.

27 Mar 2012

Blue Spark to Demonstrate Applications of Low-Voltage Printed Batteries at German Conference

Blue Spark Technologies, a provider of thin, environmentally friendly, flexible printed batteries, has disclosed that the company will participate in Printed Electronics Europe 2012.

27 Mar 2012

Novavax to Discuss Phase I Study Results of RSV Nanoparticle Vaccine at Turkey Conference

Louis F. Fries III, Vice President of Clinical and Medical Affairs at Novavax, will present the Phase I clinical study results of the company’s recombinant nanoparticle vaccine candidate for respiratory syncytial virus (RSV) at the XIV International Symposium on Respiratory Viral Infections to be conducted from March 24 to 26, 2012 in Istanbul, Turkey.

From Novavax Inc. 26 Mar 2012

Nanoparticle Radiation Technique for Target-Specific Treatment of Brain Tumors

Scientists at The University of Texas Health Science Center at San Antonio have developed a nanoparticle radiation technique to deliver radiation straightaway to the brain tumor and make it stay there.

22 Mar 2012